share_log

康方生物-B:自願公告 - 開坦尼(卡度尼利單抗注射液)獲納入CSCO宮頸癌診療指南(2022)

AKESO, INC. - B: VOLUNTARY ANNOUNCEMENT - (CADONILIMAB INJECTION) BEING INCLUDED IN CSCO GUIDELINES FOR CERVICAL CANCER TREATMENT (2022)

Oct 16, 2022 19:57
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more